Skip to content

PREMO Study: to Investigate Port REMoval Outcomes

Pilot Trial to Assess Functional, Microbial, Radiological and Patient Reported Outcomes at Totally Implantable Venous Access Device (Port) Removal (PREMO Study)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03948958
Acronym
PREMO
Enrollment
100
Registered
2019-05-14
Start date
2019-06-28
Completion date
2022-07-08
Last updated
2022-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis, Neoplasms

Keywords

Vascular Access Devices, Implantable port, Flush interval, Catheter function, Catheter-related infection, Catheter tip location, Catheter tip thrombus, Catheter sleeve, Patient-reported outcome measure

Brief summary

A Totally Implantable Venous Access Device (TIVAD) that is no longer in use for intravenous therapy, should be flushed at established intervals to promote and maintain patency. No consensus has been established regarding the optimal duration of the interval between 2 maintenance sessions. This exploratory study will focus on catheter status under the current 3-monthly flush regimen.

Detailed description

A Totally Implantable Venous Access Device (TIVAD) or so called implantable port that is no longer in use for intravenous therapy, should be removed or flushed at established intervals to promote and maintain patency. The maintenance procedure consists of a 10 ml 0.9% sodium chloride pulsatile flush. No consensus has been established regarding the optimal duration of the interval between 2 maintenance sessions. In het university hospitals Leuven the current interval is 3 months. Studies confirmed the safety and efficacy of an extended maintenance interval to once every 4 months. Many patients have relatively poor compliance with their regular port flushing procedure. Clinicians tend to prolong the recommended interval or even to omit the maintenance procedure. Therefore in clinical practice, intervals vary widely among institutions. To the best of our knowledge, a comprehensive investigation of the risks related to catheter patency, bacterial colonization and catheter integrity, has never been performed in patients whose port is electively removed using a 3 months flushing maintenance regimen. To assess the impact of the maintenance interval, patients will be included in the study if the patient's TIVAD is not being used for regularly therapy for a total period of at least one year. This exploratory study will focus on catheter function and colonisation, tip position and tip thrombosis, sleeve formation, removal problems and also patient experiences at elective planned TIVAD removal therapy.

Interventions

OTHEREvaluation of the catheter function

Catheter function will be measured by the CINAS (Catheter injection and aspiration classification)

OTHERCatheter tip location, thrombus, sleeve and device damage visualization

Catheter tip location, thrombus, sleeve and device damage will be visualized by linogram

OTHERCatheter-related colonization

TIVAD colonization will be investigated by microbiological culture of the tip and chamber content

OTHERpatient-reported outcome measures (PROM) related to the presence of the TIVAD

PROM will evaluate patient's experiences regarding the TIVAD insertion, dwell time, and removal using the Leuven Patient Reported Experiences at Port removal (Leuven PREP) questionnaire.

OTHERMacroscopic evaluation of the port chamber and catheter

Macroscopic evaluation of the port chamber and catheter will be performed after port removal.

Sponsors

B. Braun Medical SA
CollaboratorINDUSTRY
Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients of 18 years and older, with a TIVAD that is no longer used for intravenous therapy on a regular basis for the past 365 days after completing initially planned treatment. * Patients planned for an elective TIVAD removal under local anaesthesia. * Patients able to participate in the study and willing to sign an informed consent. * Patients able to understand and read Dutch.

Exclusion criteria

• History of fever and/or chills following last flushing procedure

Design outcomes

Primary

MeasureTime frameDescription
TIVAD functionduring the 1 day of TIVAD removal, before the linogramwill be assessed in terms of both injection and aspiration abilities. The ability is scored as easy, difficult or impossible along the Catheter Injection and Aspiration (CINAS) classification.

Secondary

MeasureTime frameDescription
Catheter tip position visualization by fluoroscopyduring the 1 day of TIVAD removal, just before the linogramThe patient will be positioned in a nearly standing position with chest elevation of 17°
Port chamber filling, sleeve formation, sleeve extend, catheter tip thrombosis and damage in port chamber or catheter trajectoryduring the 1 day of TIVAD removalwill be visualised by linogram (digital substraction angiography)
Catheter tip and port chamber cultureduring the 1 day of TIVAD removal (following TIVAD removal)microbial culture

Other

MeasureTime frameDescription
Patient-reported outcome measureduring the 1 day of TIVAD removalPatient's experiences will be collected by means of the Leuven Patient Reported Experiences at Port removal (Leuven PREP) questionnaire a self-reported 25-items questionnaire

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026